The antigen receptors on T and B lymphocytes -the T-cell receptor (TCR) and B-cell receptor (BCR), respectively -are multimeric complexes comprising a receptor module that is non-covalently associated with various signaling proteins (CD3 and the TCRζ chain in T cells and immunoglobulin α and β in B cells). These complexes initiate intracellular signaling by engaging proximal protein tyrosine kinases of the Src kinase family. The association of the T-cell-specific Src-family kinase Lck with the CD4 and CD8 T-cell co-receptors brings the kinase into proximity with the TCRζ-CD3 complex, thereby promoting tyrosine phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) on the TCRζ and CD3 chains. The phosphorylation of the two tyrosine residues in the ITAM allows the Src homology 2 (SH2) domains of another lymphoid-specific kinase, Zap-70, to bind in tandem to the TCR. Subsequent Lck-mediated phosphorylation of Zap-70 is then needed for Zap-70 activation and the phosphorylation of downstream targets. The SH2 domain of Lck can also bind to Zap-70 thereby consolidating the presence of CD4-Lck or CD8-Lck in the TCRζ-CD3 complex.
The antigen receptors on T and B lymphocytes -the T-cell receptor (TCR) and B-cell receptor (BCR), respectively -are multimeric complexes comprising a receptor module that is non-covalently associated with various signaling proteins (CD3 and the TCRζ chain in T cells and immunoglobulin α and β in B cells). These complexes initiate intracellular signaling by engaging proximal protein tyrosine kinases of the Src kinase family. The association of the T-cell-specific Src-family kinase Lck with the CD4 and CD8 T-cell co-receptors brings the kinase into proximity with the TCRζ-CD3 complex, thereby promoting tyrosine phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) on the TCRζ and CD3 chains. The phosphorylation of the two tyrosine residues in the ITAM allows the Src homology 2 (SH2) domains of another lymphoid-specific kinase, Zap-70, to bind in tandem to the TCR. Subsequent Lck-mediated phosphorylation of Zap-70 is then needed for Zap-70 activation and the phosphorylation of downstream targets. The SH2 domain of Lck can also bind to Zap-70 thereby consolidating the presence of CD4-Lck or CD8-Lck in the TCRζ-CD3 complex.
Unlike growth factor receptors, TCRζ-CD3 complexes are not simple binary on-off signaling switches. Instead, the peptide ligand of the TCR, as presented in the peptidebinding groove of a major histocompatibility complex (MHC) molecule, can induce a range of responses -negative responses if it is an antagonist, partial responses if a partial agonist and optimal activation if an agonist. The level of response depends on the avidity of peptide binding, on the on-off rates and on the degrees of receptor aggregation. In an exciting new study, Neumeister Kersh et al. [1] have shed new light on the molecular basis by which these quantitative differences in binding can potentially be translated into qualitatively different biological responses.
Previous studies had shown that the three distinct ITAMs of the TCRζ chain are critical for a response to the MHC-peptide complex. The TCRζ chain is found as an unphosphorylated 16 kDa species and as a partially phosphorylated 21 kDa species in resting T cells, undergoing further phosphorylation to a 21 kDa and/or a 23 kDa species upon receptor crosslinking. Using antisera specific for the individual phosphorylation sites of the three ITAMs, Neumeister Kersh et al. [1] uncovered an ordered, hierarchical mode by which the individual sites become phosphorylated in response to different types of peptide. In this scheme, the phosphoryation of one tyrosine residue required the presence of another. Further, while the TCRζ chain in resting T cells has monophosphorylated ITAMs, partial agonist peptides induce a discrete pattern of phosphorylation amongst individual ITAMs and potent agonists cause the phosphorylation of all ITAMs. Phosphorylation of the last two tyrosines in the sequence depended directly on the strength of the agonist. The expectation from these studies is that different stages of ordered phosphorylation will be found to differentially engage the effector of the response -Zap-70 and/or some other molecule. In this context, monophosphorylated ITAMs in resting T cells were sufficient for the recruitment of one Zap-70 molecule, while fully phosphorylated ζ could recruit as many as three Zap-70 molecules. The process may be more subtle than this, however, because results indicate that the progressive phosphorylation of intermediate forms of TCRζ -and thus the progressive recruitment of Zap-70 -did not necessarily lead to Zap-70 activation.
Although the TCRζ chain is the focus of early molecular changes, it is not the only member of the receptor complex with the potential to generate intracellular signals. Bruyns et al. [2] have recently identified a new dimeric structure (termed TRIM for T-cell receptor interacting molecule) that loosely associates with the receptor complex. TRIM is a member of a growing family of dimeric type III transmembrane proteins, which have a short extracellular region attached to an extended cytoplasmic tail. As with the TCRζ chain, the small extracellular region of TRIM is unlikely to bind directly to ligand. Instead, it may act as a cell-surface adaptor that is engaged by adjacent receptors. Interestingly, instead of possessing ITAMs, TRIM has six tyrosine residues in its intracellular region that include SH2-domain-binding motifs for Src kinases and for phosphatidylinositol 3-kinase. TRIM is therefore unlikely to be a simple homolog of TCRζ, and instead carries the potential to induce signaling pathways that are linked to other functions. An analogous molecule is the previously cloned type III transmembrane protein LAT (linker for activation of T cells) which associates with numerous SH2-domain-containing signaling proteins, such as the adaptor protein Grb2, phosphatidylinositol 3-kinase, phospholipase Cγ (PLCγ) and others [3] .
In addition to elucidating cell-surface events, rapid recent progress has also been made in identifying downstream targets of the T-cell signaling cascade. A key issue concerns the mechanism by which proximal lymphoidrestricted signaling proteins connect with more general signal transducers, such as PLCγ and Ras, and the degree to which this is linked to the regulation of immune-specific functions. Studies over the past couple of years have identified several key lymphoid-restricted signaling proteins, including Slp-76 (SH2-domain-containing leucocyte protein of 76 kDa), Fyb (FynT-binding protein, FynT being the T-cell-specific isoform of the Src-family kinase Fyn) or Slap (for Slp-76-associated protein), and Skap55 (Src-kinase-associated protein of 55 kDa). Each protein has a unique amino-terminal region with either a SH2 or SH3 domain at the carboxyl terminus. Each also undergoes an increase in tyrosine phosphorylation in response to TCR crosslinking. Of particular interest is Slp-76 [4] , a downstream target of Zap-70 [5, 6] . One remarkable feature of this protein is its ability to bind to multiple effector proteins such as PLCγ, the adaptor proteins Grb2 and Nck, and the hematopoietic GTP-exchange protein Vav (Figure 1 ). In this regard, Slp-76 has the potential to act as a central adaptor protein that links the TCR to the activation of lipid metabolism (via PLCγ), serine/threonine kinases and GTP-binding proteins such as Ras, Rho and Rac (via Vav). Slp-76 has a central proline-rich region with several tyrosine phosphorylation sites and has a carboxy-terminal SH2 domain. The proline residues interact with SH3-domain-containing proteins such as Grb2, while two tyrosine-based motifs interact with the SH2 domain of Vav. Furthermore, overexpression of Slp-76 can augment TCR-induced transcription of the T-cell growth factor interleukin-2, a key consequence of TCR signaling; this effect is dependent on the SH2 domain of Slp-76.
In addition to binding general downstream effector proteins, Slp-76 binds to lymphoid-specific proteins. The SH2 domain of Slp-76 binds to at least two proteins, one of which corresponds to the lymphoid-specific protein Fyb/Slap [7, 8] . Fyb/Slap is expressed only in T cells and myeloid cells, and it has a several proline-rich regions, multiple tyrosine-containing motifs and two putative nuclear localization sequences linked to a carboxy-terminal SH3-like domain. Two Fyb/Slap isoforms of 120 kDa and 130 kDa are known, which differ because of a 46 amino-acid insert in the 130 kDa form between the two nuclear localization sequences (my group's unpublished observations). In an unusual twist, Fyb/Slap is phosphorylated by and binds selectively to the SH2 domain of FynT. This provides a specific avenue by which the FynT kinase could intervene in signaling. Although the details are still unclear, overexpression of Fyb/Slap has been found to slightly increase interleukin-2 release [7] and to have either no effect or a negative effect on interleukin-2 transcription [7, 8] .
In addition to these players, Liu et al. [9] , using a twohybrid screen, have recently identified two new Fybbinding proteins that correspond to the previously cloned Skap55 [10] and a new Skap55-related protein (Skap55R). In this case, the SH3 domains of Skap55 and Skap55R bind to Fyb. Skap55 has a central pleckstrin homology domain and a carboxy-terminal SH3 domain. Skap55R has a similar overall structure to Skap55, except that Skap55R has a coiled-coil loop at the amino terminus. Coiled-coil domains tend to bind tightly to each other and are found in fibrous proteins, such as tropomyosin, as well as transcriptional activators, such as the homeobox-containing protein Ubx. Thus, while Skap55R might generate similar signals to Skap55, it may also differ in its intracellular localization and/or generate unique signals due to its coiled-coil region. As with Fyb/Slap, Skap55 Given this array of newly identified lymphoid proteins, what then is their function? Three recent papers have reported exciting evidence for a central role for Slp-76 in signaling from the TCR in mature T cells, and in signaling in immature thymocytes via the pre-TCR which comprises a TCRβ chain and a pTα chain [11] [12] [13] . Upon reaching the thymus, the newly seeded thymocyte undergoes differentiation and the stages of this process can be characterized by changes in expression of cell-surface markers, commonly the co-receptors CD4 and CD8 (Figure 2 ). The earliest thymocytes progress from a CD4 -CD8 -(double negative, DN) stage to a CD4 + CD8 + (double positive, DP) stage and in their fully differentiated form express only one of the co-receptors, being CD4 + or CD8 + (single positive, SP). Slp-76-deficient thymocytes show a profound block at a specific step during the differentiation of DN thymocytes (which is further characterized by cell-surface markers as being CD25 + CD44 -) [11, 12] . At this point under normal conditions the TCRβ chain is rearranged and the pre-TCR assembles; pre-TCR signaling can then induce progression to DP cells. Although they showed normal TCRβ chain rearrangement, Slp-76-deficient thymocytes were defective in pre-TCR signaling as demonstrated by the inability of pre-TCR crosslinking to induce the appearance of DP cells [12] . An additional defect in the Slp-76-deficient mice was severe hemorrhaging -possibly due to an effect on platelets -which resulted in decreased viability. Slp-76 is therefore required for the pre-TCR signaling events that mediate progression from the DN to DP stage of thymic development.
Perhaps not surprisingly, given the kinase-substrate relationship between Zap-70 or Syk and Slp-76, Slp-76-deficient mice have a similar phenotype to mice which lack both Zap-70 and Syk expression [14] . This finding could be interpreted to imply a cause-effect connection between kinase and substrate in pre-TCR signaling. It is questionable whether the ability of Zap-70 to promote Vav binding to Slp-76 is important in this pathway, because DP thymocytes develop normally in Vav-deficient mice. By contrast, like Slp-76-deficient mice, Lckdeficient mice also show a partial block at the DN stage, but are additionally defective in β-chain rearrangement. This finding points to a distinction between Lck and Slp-76 in which Lck is required for a further earlier event in differentiation. Nevertheless, mice lacking Lck and Fyn show a complete arrest at the DN stage indicating that both of these Src-related kinases are also needed for pre-TCR signaling [15, 16] . Slp-76 could therefore act as a common downstream target for upstream signals generated by the Lck, Fyn, Zap-70 and Syk kinases.
As well as being required for pre-TCR signaling, Slp-76 is necessary for signaling from the mature TCR. A study by Yablonski et al. [13] using a Slp-76-deficient T-cell line outlined a more detailed view of the connection between Slp-76 and other signaling events (Figure 1 ). In these cells, many events were reduced or absent, including activation of the mitogen-activated protein kinase Erk2, phosphorylation of PLCγ1, production of inositol phosphates, increases in intracellular Ca 2+ concentration, and expression of the activation marker CD69. TCR crosslinking was completely uncoupled from transcriptional activation of the interleukin-2 promoter mediated by the transcription factor NFAT, and partially uncoupled from activation of the promoter by the transcription factor AP-1. An important finding was that the loss of PLCγ1 phosphorylation occurred without a loss in tyrosine phosphorylation of other substrates. This points to a specific scaffolding role for Slp-76 in bridging a protein tyrosine kinase with PLCγ1.
Slp-76-deficient mice showed no obvious defects in B-cell development or function [11, 12] suggesting the existence of a B-cell homolog of Slp-76. Indeed, two recent studies have identified such a potential homolog termed Blnk (B cell linker protein)/Slp-65 [17, 18] (Figure 3) . Notably, Blnk/Slp-65 has the same overall structure as Slp-76 and can bind to PLCγ, Grb2, Vav and Nck. Blnk/Slp-65 also activates PLCγ activity and upregulates NFAT activity [17] . Slp-76 and Blnk/Slp-65 have therefore co-evolved as adaptors linking the antigen receptors with downstream signaling processes. The rationale for different forms of the protein in T and B cells may relate to their different regulatory effects on Erk kinases. Unlike Slp-76, Blnk/Slp-65 failed to activate the kinase in transfection studies. We cannot exclude an additional possibility that these proteins might use the more general signaling pathways to provide an appropriate signaling background for the mediation of lymphoid-specific functions through their interaction with Fyb/Slap and a potential B-cell homolog. Functional and knock-out studies on Fyb/Slap and Skap55 and their potential B-cell homologs will provide an exciting sequel to the studies of Slp-76.
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Figure 3
The Slp-76 homolog Blnk/Slp-65 in B cells. Signaling from the BCR is mediated by antigen receptor complex crosslinking followed by activation of Fyn, Lyn, Blk, Syk and Btk. Blnk/Slp-65 has the same overall structure as Slp-76, and shares the ability to bind PLCγ, Grb2, Vav and Nck. The identification of Blnk/Slp-65 points to the conserved nature of basic signaling mechanisms in B and T cells. 
